The global single-use bioreactors market was valued at US$ 2.1 billion in 2023 and is projected to expand at a CAGR of 10.8% from 2024 to 2034, reaching approximately US$ 6.7 billion by the end of 2034. This growth is driven by advancements in biopharmaceutical production, particularly in the development of monoclonal antibodies, recombinant proteins, and vaccines. Don't Miss Out: Get Your...